Science and Technology

1
Science and Technology
2
Target Market Identification

Market Analysis
Short-Term Target Markets
Peripheral Arterial Disease Market Size 1B
Direct Costs 17 CAGR Competition
Low Preliminary Data Blood flow restored to
limbs
Cancer Vaccines Market Size 78B Direct
Costs 11 CAGR Competition
Moderate Preliminary Data Dendritic cells
recruited
Rev. (B)
Rev. (B)
Peripheral Arterial Disease
Yes
Cancer vaccines
Heart Disease
Diabetes mellitus
Preliminary Animal Data
Long-Term Target Markets
Parkinsons disease
Ischemic Heart Disease Market Size 150B Direct
Indirect Competition Moderate Preliminary
Data Anticipated
Diabetes Mellitus Market Size 80B Direct
Costs Competition High Preliminary Data
Anticipated
Skin regeneration
Umbilical cord blood therapies
Bone regeneration
No
High
Low
Competition
25B Market Size
3
Development Plan
Development Plan

• Staged approach to assess value of technology
  through in-depth proof of concept experiments
• Focus on near-term market opportunities
• Partner to develop cancer vaccine technology
• Use partnership funding to develop Peripheral
  Arterial Disease (PAD) technology in-house

Secure licensing agreement continue animal
studies
Begin clinical trials
Animal studies
Conduct PAD large animal testing (6 months, 250K)
Conduct dendritic cell cancer vaccine small
animal testing (12 months, 250K)

• Incorporate CCD start-up
• Hire key personnel
• CEO, Chief Science Officer, VP of Business
  Development
• License CCD technology from Harvard OTD
• Apply for additional blocking patents

• Continue research in Mooney lab to assess CCD
  technology
• Use grant funding
• Requires 2 researcher FTEs